Septic shock is a potentially lethal consequence of gram negative and positive bacterial infection and is a significant complication in victims of traumatic injury. There are multiple bacterial products implicated as pathogenic molecules including bacterial lipoproteins, lipopolysaccharide, (LPS), lipoteichoic acid, peptidoglycans, cell wall products, etc. Sepsis in experimental animals was shown to activate the intrinsic cell """"""""suicide"""""""" program leading to apoptosis in multiple cell types. Insights into the molecular basis of cellular activation/apoptosis in response to sepsis are under intense investigation in the hope of finding new approaches to therapy. Signaling by bacterial products occurs through the recently described Toll-like receptors (TLR) on the surface of cells. Intracellular pathways leading to NFkappaB activation proceed along similar pathways for TLR-2 and TLR-4 (the two receptors shown to respond to bacterial products). However, apoptosis pathways have received less attention. The investigators will examine sepsis-induced apoptosis and a novel activation pathway in vitro as well as the effect of gene alterations that lead to decreased apoptosis in monocytes, lymphocytes and endothelial cells in vivo. They have recently shown that the apoptotic pathway following stimulation with LPS proceeds through FADD dependent signaling and that blockade of NFkappaB does not sensitize endothelial cells to death. These observation lead to questions regarding the death pathway and intrinsic cyto-protective pathways. Since considerable apoptosis occurs in LPS resistant (TLR-4 deficient) mice during sepsis, we also speculate that TLR-2 provides both activation signals and death signals in TLR-4 deficient mice. Also, they have observed two pathways leading to endothelial cell activation. First, mice lacking functional Fas (lpr) or FasL (gld) have reduced responses to LPS, and they postulate that the Fas-FasL system is pro-imflammatory. Second, a specific caspase-8 inhibitor reduces LPS-induced VCAM-1 expression. They postulate that this protease also signals for endothelial cell activation.
The specific aims of this project are: 1) To determine the role of MyD88, Il-1 receptor- associated kinase and TNF receptor- associated factor-6 in sepsis-induced apoptosis of monocytes/macrophages and endothelial cells; 2) To determine the contribution of Fas-FasL and other molecules in that apoptosis pathway in LPS-induced inflammatory response of endothelial cells; and 3) To examine the effects of apoptotic gene alterations in monocytes, lymphocytes or endothelial in survival following induction of sepsis in mice.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM042686-12
Application #
6519351
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Somers, Scott D
Project Start
1990-04-01
Project End
2004-05-31
Budget Start
2002-06-01
Budget End
2003-05-31
Support Year
12
Fiscal Year
2002
Total Cost
$234,080
Indirect Cost
Name
University of Washington
Department
Surgery
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Iwata, Akiko; de Claro, R Angelo; Morgan-Stevenson, Vicki L et al. (2011) Extracellular administration of BCL2 protein reduces apoptosis and improves survival in a murine model of sepsis. PLoS One 6:e14729
Iwata, Akiko; Morgan-Stevenson, Vicki; Schwartz, Barbara et al. (2010) Extracellular BCL2 proteins are danger-associated molecular patterns that reduce tissue damage in murine models of ischemia-reperfusion injury. PLoS One 5:e9103
Bannerman, Douglas D; Eiting, Kristine T; Winn, Robert K et al. (2004) FLICE-like inhibitory protein (FLIP) protects against apoptosis and suppresses NF-kappaB activation induced by bacterial lipopolysaccharide. Am J Pathol 165:1423-31
Iwata, Akiko; Stevenson, Vicki Morgan; Minard, Annie et al. (2003) Over-expression of Bcl-2 provides protection in septic mice by a trans effect. J Immunol 171:3136-41
Erwert, Ryan D; Eiting, Kristine T; Tupper, Joan C et al. (2003) Shiga toxin induces decreased expression of the anti-apoptotic protein Mcl-1 concomitant with the onset of endothelial apoptosis. Microb Pathog 35:87-93
Erwert, Ryan D; Winn, Robert K; Harlan, John M et al. (2002) Shiga-like toxin inhibition of FLICE-like inhibitory protein expression sensitizes endothelial cells to bacterial lipopolysaccharide-induced apoptosis. J Biol Chem 277:40567-74
Iwata, Akiko; Harlan, John M; Vedder, Nicholas B et al. (2002) The caspase inhibitor z-VAD is more effective than CD18 adhesion blockade in reducing muscle ischemia-reperfusion injury: implication for clinical trials. Blood 100:2077-80
Bannerman, Douglas D; Erwert, Ryan D; Winn, Robert K et al. (2002) TIRAP mediates endotoxin-induced NF-kappaB activation and apoptosis in endothelial cells. Biochem Biophys Res Commun 295:157-62
Bannerman, Douglas D; Tupper, Joan C; Erwert, Ryan D et al. (2002) Divergence of bacterial lipopolysaccharide pro-apoptotic signaling downstream of IRAK-1. J Biol Chem 277:8048-53
Bannerman, Douglas D; Tupper, Joan C; Kelly, James D et al. (2002) The Fas-associated death domain protein suppresses activation of NF-kappa B by LPS and IL-1 beta. J Clin Invest 109:419-25

Showing the most recent 10 out of 35 publications